Sexual function post-breast cancer

Lauren Streicher*, James A. Simon

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer International Publishing
Pages167-189
Number of pages23
DOIs
StatePublished - Jan 1 2018

Publication series

NameCancer Treatment and Research
Volume173
ISSN (Print)0927-3042

Keywords

  • DHEA
  • Dyspareunia
  • Female sexual dysfunction
  • Fractional CO2 laser
  • Genitourinary syndrome of menopause
  • Hypoactive sexual desire disorder
  • Ospemifene
  • Prasterone
  • Vaginal estrogen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Sexual function post-breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Streicher, L., & Simon, J. A. (2018). Sexual function post-breast cancer. In Cancer Treatment and Research (pp. 167-189). (Cancer Treatment and Research; Vol. 173). Springer International Publishing. https://doi.org/10.1007/978-3-319-70197-4_11